瓣膜性-话题@MedSci - 梅斯（MedSci）

#瓣膜性#

56篇内容 | 1791人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1798255, encodeId=06501e9825537, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JAHA：卒中合并非瓣膜性房颤，既往DOAC治疗有哪些益处？, objectType=article, longId=148742, objectId=9ccd148e4298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ccd148e4298, replyNumber=0, likeNumber=62, createdTime=2019-03-28, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ccd148e4298, moduleTitle=JAHA：卒中合并非瓣膜性房颤，既往DOAC治疗有哪些益处？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9ccd148e4298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798256, encodeId=3a9d1e982565f, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Diabetic Med：利伐沙班与华法林治疗非瓣膜性心房颤动和糖尿病患者的有效性和安全性, objectType=article, longId=152527, objectId=351015252e50, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=351015252e50, replyNumber=0, likeNumber=71, createdTime=2019-03-30, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=351015252e50, moduleTitle=Diabetic Med：利伐沙班与华法林治疗非瓣膜性心房颤动和糖尿病患者的有效性和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=351015252e50)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798261, encodeId=8bff1e9826102, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, objectType=article, longId=156509, objectId=fcba1565093c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcba1565093c, replyNumber=0, likeNumber=94, createdTime=2019-05-23, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcba1565093c, moduleTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fcba1565093c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798259, encodeId=eb8e1e9825915, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Stroke：非瓣膜性心房颤动患者口服抗凝剂的有效性和安全性研究, objectType=article, longId=155912, objectId=379b1559127a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379b1559127a, replyNumber=0, likeNumber=60, createdTime=2019-05-12, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379b1559127a, moduleTitle=Stroke：非瓣膜性心房颤动患者口服抗凝剂的有效性和安全性研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=379b1559127a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798252, encodeId=55fa1e98252e1, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JAHA：新型口服抗凝剂vs.华法林治疗房颤和瓣膜性心脏病的安全性和疗效, objectType=article, longId=135150, objectId=ed6e135150b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed6e135150b5, replyNumber=0, likeNumber=105, createdTime=2019-02-08, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed6e135150b5, moduleTitle=JAHA：新型口服抗凝剂vs.华法林治疗房颤和瓣膜性心脏病的安全性和疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ed6e135150b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798258, encodeId=92381e9825827, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林, objectType=article, longId=153169, objectId=dfd415316946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfd415316946, replyNumber=0, likeNumber=90, createdTime=2019-02-18, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfd415316946, moduleTitle=Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dfd415316946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798254, encodeId=c4f71e98254d1, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Circulation：直接口服抗凝剂与华法林治疗非瓣膜性心房颤动的围手术期结局！, objectType=article, longId=139183, objectId=bc1213918330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc1213918330, replyNumber=0, likeNumber=73, createdTime=2019-04-11, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc1213918330, moduleTitle=Circulation：直接口服抗凝剂与华法林治疗非瓣膜性心房颤动的围手术期结局！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bc1213918330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798253, encodeId=84911e982537d, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Heart：心脏听诊不能预测无症状原发性心脏病患者瓣膜性心脏病！, objectType=article, longId=139101, objectId=a60713910107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a60713910107, replyNumber=0, likeNumber=96, createdTime=2018-06-25, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a60713910107, moduleTitle=Heart：心脏听诊不能预测无症状原发性心脏病患者瓣膜性心脏病！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a60713910107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798257, encodeId=ebde1e9825797, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系, objectType=article, longId=152787, objectId=9f72152e871d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f72152e871d, replyNumber=0, likeNumber=70, createdTime=2018-11-07, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f72152e871d, moduleTitle=JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f72152e871d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798250, encodeId=105d1e982505e, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？, objectType=article, longId=119554, objectId=379c11955440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379c11955440, replyNumber=0, likeNumber=93, createdTime=2018-07-13, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379c11955440, moduleTitle=Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=379c11955440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798247, encodeId=26bf1e98247ef, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？, objectType=article, longId=117839, objectId=06ed11e83930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06ed11e83930, replyNumber=0, likeNumber=106, createdTime=2018-07-17, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06ed11e83930, moduleTitle=Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=06ed11e83930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798249, encodeId=b6cc1e98249cd, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！, objectType=article, longId=118856, objectId=23071188567a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23071188567a, replyNumber=0, likeNumber=101, createdTime=2018-01-10, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23071188567a, moduleTitle=Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=23071188567a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798244, encodeId=a4901e982443c, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=早期确诊瓣膜性心脏病主要靠……, objectType=article, longId=111162, objectId=9b7311116285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b7311116285, replyNumber=0, likeNumber=68, createdTime=2018-08-07, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b7311116285, moduleTitle=早期确诊瓣膜性心脏病主要靠……, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9b7311116285)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798245, encodeId=14d41e982454d, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JAHA：瓣膜性心脏病合并AF：NOAC vs华法林, objectType=article, longId=112900, objectId=0d15112900c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d15112900c2, replyNumber=0, likeNumber=68, createdTime=2017-12-11, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d15112900c2, moduleTitle=JAHA：瓣膜性心脏病合并AF：NOAC vs华法林, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0d15112900c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798251, encodeId=03ff1e982516c, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, objectType=article, longId=134289, objectId=c5a613428989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5a613428989, replyNumber=0, likeNumber=68, createdTime=2018-10-27, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5a613428989, moduleTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c5a613428989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798248, encodeId=a68c1e98248a2, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=J Thromb Haemost：非瓣膜性房颤患者：利伐沙班vs阿哌沙班, objectType=article, longId=118427, objectId=984711842e9a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=984711842e9a, replyNumber=0, likeNumber=104, createdTime=2018-01-13, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=984711842e9a, moduleTitle=J Thromb Haemost：非瓣膜性房颤患者：利伐沙班vs阿哌沙班, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=984711842e9a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798246, encodeId=a5851e9824676, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Br J Clin Pharmacol：非瓣膜性房颤：利伐沙班可显著减少稳态谷浓度时凝血酶生成？, objectType=article, longId=116513, objectId=8e8f1165138d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e8f1165138d, replyNumber=0, likeNumber=91, createdTime=2018-08-27, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e8f1165138d, moduleTitle=Br J Clin Pharmacol：非瓣膜性房颤：利伐沙班可显著减少稳态谷浓度时凝血酶生成？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8e8f1165138d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798242, encodeId=d4a11e9824280, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Heart：临床对瓣膜性心脏疾病的诊断报告真的准确吗？, objectType=article, longId=102526, objectId=98dc1025260d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98dc1025260d, replyNumber=0, likeNumber=78, createdTime=2018-01-03, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98dc1025260d, moduleTitle=Heart：临床对瓣膜性心脏疾病的诊断报告真的准确吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=98dc1025260d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798241, encodeId=bd141e982413e, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Heart：瑞典瓣膜性心脏病的流行病学分析！, objectType=article, longId=99309, objectId=554499309c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=554499309c2, replyNumber=0, likeNumber=71, createdTime=2018-03-04, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=554499309c2, moduleTitle=Heart：瑞典瓣膜性心脏病的流行病学分析！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=554499309c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798240, encodeId=81d81e98240e4, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JAMA：达比加群vs.华法林-预防非瓣膜性房颤患者发生骨折哪个更好？, objectType=article, longId=93326, objectId=c27593326f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c27593326f5, replyNumber=0, likeNumber=82, createdTime=2017-07-19, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c27593326f5, moduleTitle=JAMA：达比加群vs.华法林-预防非瓣膜性房颤患者发生骨折哪个更好？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c27593326f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

瓣膜性

2020-05-29

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JAHA：卒中合并非瓣膜性房颤，既往DOAC治疗有哪些益处？

2019-03-28

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Diabetic Med：利伐沙班与华法林治疗非瓣膜性心房颤动和糖尿病患者的有效性和安全性

2019-03-30

一叶知秋 (审核中...)

前往app查看评论内容

#瓣膜性#

Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？

2019-05-23

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Stroke：非瓣膜性心房颤动患者口服抗凝剂的有效性和安全性研究

2019-05-12

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JAHA：新型口服抗凝剂vs.华法林治疗房颤和瓣膜性心脏病的安全性和疗效

2019-02-08

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林

2019-02-18

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Circulation：直接口服抗凝剂与华法林治疗非瓣膜性心房颤动的围手术期结局！

2019-04-11

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Heart：心脏听诊不能预测无症状原发性心脏病患者瓣膜性心脏病！

2018-06-25

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系

2018-11-07

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？

2018-07-13

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？

2018-07-17

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！

2018-01-10

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

早期确诊瓣膜性心脏病主要靠……

2018-08-07

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JAHA：瓣膜性心脏病合并AF：NOAC vs华法林

2017-12-11

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？

2018-10-27

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

J Thromb Haemost：非瓣膜性房颤患者：利伐沙班vs阿哌沙班

2018-01-13

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Br J Clin Pharmacol：非瓣膜性房颤：利伐沙班可显著减少稳态谷浓度时凝血酶生成？

2018-08-27

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Heart：临床对瓣膜性心脏疾病的诊断报告真的准确吗？

2018-01-03

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Heart：瑞典瓣膜性心脏病的流行病学分析！

2018-03-04

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JAMA：达比加群vs.华法林-预防非瓣膜性房颤患者发生骨折哪个更好？

2017-07-19

科室
- - 订阅+
  - 更多科室
工具
服务